Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.92 CHF | +0.83% |
|
-0.78% | +10.66% |
Jun. 14 | EU regulator mandates label updates on CAR-T cancer therapies | RE |
Jun. 14 | PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.66% | 215B | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+6.24% | 164B | |
-4.79% | 155B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis' Cosentyx Receives Canadian Approval for Hidradenitis Suppurativa Treatment